{"denomUnitsSelected":"Participants","description":"To assess the potential for aprepitant and cyclophosphamide to interact pharmacokinetically in a significant manner to change blood levels of aprepitant, cyclophosphamide, hydroxycyclophosphamide or CEPM.","reportingStatus":"NOT_POSTED","timeFrame":"Up to three weeks","title":"Pharmacokinetic Interaction","type":"SECONDARY"}